Vassilios Papadopoulos, DPharm, PhD, DSc (hon)
Dean, USC School of Pharmacy
John Stauffer Dean's Chair in Pharmaceutical Sciences
Professor of Pharmacology and Pharmaceutical Sciences
- 1985 Zonal Avenue, Los Angeles, CA 90089-9121
- PSC 700
DPharm, University of Athens
PhD, University Pierre and Marie Curie
In October 2016, Vassilios Papadopoulos was appointed as the Dean of the School of Pharmacy at the University of Southern California. He also holds the John Stauffer Dean’s Chair in Pharmaceutical Sciences and he is a professor of Pharmacology & Pharmaceutical Sciences at USC. A graduate of the School of Pharmacy of the University of Athens, Greece, Dr. Papadopoulos completed his PhD in Health and Life Science at the Université Pierre et Marie Curie in Paris, France. He continued as a post-doctoral researcher in France and Australia. In 1988, he joined the faculty of Georgetown University’s School of Medicine in Washington D.C. where he rose through the ranks to become professor and chair of the Department of Biochemistry and Molecular Biology. In 2004, Dr. Papadopoulos was appointed associate vice president for research and then director of the Biomedical Graduate Research Organization at Georgetown University Medical Centre. Dr. Papadopoulos served from 2007-2016 as the executive director and chief scientific officer of the Research Institute of the McGill University Health Centre (RI-MUHC), one of Canada’s largest research centres. At the RI-MUHC he was a professor in the Faculty of Medicine at McGill University and held a Canada Research Chair in Biochemical Pharmacology and the Phil Gold Chair in Medicine at McGill and the MUHC.
Dr. Papadopoulos’ research focus is in the pathophysiology and treatment of diseases related to altered steroid hormone synthesis, including endocrine pathologies, male reproductive disorders, neuropathologies and cancer. His research has led to a better understanding of the pathways leading to steroid hormone synthesis, the pharmacology of steroid formation in the periphery and brain, the identification of new molecules targeting key elements in diseases where steroids play a determining role, and the development of diagnostics for these diseases. This work has been supported by grants and contracts from the National Institutes of Health, the National Science Foundation, US Department of Defense, Canadian Institutes of Health Research, Canadian Foundation of Innovation, private foundations, as well as the pharmaceutical industry.
He has published more than 300 articles and holds many patents. His work has been cited over 18,000 times. He is the recipient of numerous awards and an elected foreign member of the National Academy of Pharmacy and the National Academy of Medicine in France, a fellow of the American Association for the Advancement of Science in the United States and a fellow of the Canadian Academy of Health Sciences. Dr. Papadopoulos continues to supervise graduate and postgraduate students, serves on advisory committees of various U.S., Canadian, European and other government agencies, foundations and corporations, and is on the editorial boards of several scientific journals. He has served on the board of directors and advisory boards of biotechnology companies and as a consultant for the pharmaceutical industry. Dr. Papadopoulos serves on the board of directors of non-profit corporations whose mission is to support biomedical research and improve healthcare delivery.
In addition to his scientific achievements, Dr. Papadopoulos also contributed and continues to contribute to the life of Universities and Academic Health Sciences Centers. As an administrator, Dr. Papadopoulos has worked on restructuring and reorganizing research within the University Hospital and School environments while taking advantage of emerging opportunities to successfully initiate new large scale infrastructure and research projects.